premise: 2. All Information identified as confidential and disclosed there under shall remain the sole property of the disclosing party, and the receiving party shall have no interest in or rights thereto except as set forth herein. 3. When receiving the Information each party agrees to maintain all such Information in strict confidence and to use at least the same measures to protect the same as that party uses to protect its own confidential information, including but not limited to:  restricting the information’s availability to employees, agents or consultants of the receiving party with a need to know, and making such disclosure only after they have agreed to abide by the terms and conditions of this Agreement,  prohibiting duplication of any such information without the prior written consent of the disclosing party, and  taking all necessary and reasonable precautions to prevent unauthorised disclosure. 4. With respect to the obligations of the receiving party to the protection and use of the Information, no obligations shall be imposed upon the receiving party with respect to any portion of said Information, which the receiving party can show (a) corresponds in substance to Information in the receiving party’s possession, in written or recorded forms, prior to the receiving party’s receipt of the same Information from the disclosing party; or (b) at the time of disclosure is, or thereafter becomes through no act or failure to act on the part of the receiving party, part of the public domain by publication or otherwise or (c) that it is required to disclose to the minimum extent required to do so by any order of any court of competent jurisdiction or any competent judicial, governmental or regulatory body. 5. The parties each agree not to undertake or have undertaken any analysis on the products or the technology supplied by the other parties to determine structure or composition or otherwise to perform tests not authorised by other party without the prior written consent of the other party.  Test procedures shall be mutually agreed prior to testing. 6. The parties agree to disclose to each other, the results of the tests performed in connection with the Project.  The parties each agree to take all appropriate steps to maintain and protect the confidential nature of the results.  It is explicitly agreed that the composition of the material AddiFlex as well as the manufacturing process used to produce AddiFlex shall not be the subject of any test and that all information relating to the composition and manufacture of AddiFlex shall remain the exclusive property of Add-X Biotech AB